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It has previously been shown in macaques that individual animals exhibit varying responses to challenge with the same strain of SIV. We
attempted to elucidate these differences using functional genomics and correlate them to biological response. Unfractionated PBMC from three
rhesus macaques were isolated, activated, and infected with SIVmac239. Interestingly, one of the three animals used for these experiments
exhibited a completely unique response to infection relative to the other two. After repeated attempts to infect the PBMC from this animal, little or
no infectivity was seen across the time points considered, and corresponding to this apparent lack of infection, few genes were seen to be
differentially expressed when compared to mock-infected cells. For the remaining two animals, gene expression analysis showed that while they
exhibited responses for the same groups of pathways, these responses included differences specific to the individual animal at the gene level. In
instances where the patterns of differential gene expression differed between these animals, the genes being differentially expressed were
associated with the same categories of biological process, mainly immune response and cell signaling. At the pathway level, these animals again
exhibited similar responses that could be predicted based on the experimental conditions. Even in these expected results, the degree of response
and the specific genes being regulated differed greatly from animal to animal. The differences in gene expression on an individual level have the
potential to be used as markers in identification of animals suitable for lentiviral infection experiments. Our results highlight the importance of
individual variation in response to viral challenge.
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The simian immunodeficiency virus (SIV) macaque model
is an important system for studying HIV and AIDS
progression. Macaques infected with SIV will develop
AIDS in a manner dependent on the pathogenicity of the
strain (Hirsch and Johnson, 1994). It has been demonstrated
that in vivo, individual animals exhibit different responses to
the viral challenge. In a group of macaques, certain
individuals will progress rapidly with high levels of viremia
within a normal time period for the onset of AIDS, while
others will progress more slowly or not at all, with the latter⁎ Corresponding author. Fax: +1 206 732 6055.
E-mail address: honey@u.washington.edu (M.G. Katze).
0042-6822/$ - see front matter © 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.12.015termed long-term nonprogressors (Fultz, 1993). There are also
reports of individuals progressing much faster than normal to
AIDS disease. This phenomenon is very similar to that
reported in HIV-infected humans (Sheppard et al., 1993).
In an attempt to identify the characteristics of individual
macaques that define the differences seen in infectivity and
disease progression, repeated SIVmac239 infections were
performed with the peripheral blood mononuclear cells
(PBMC) separated from the whole blood of three Macaca
mulatta. In this study, we attempt to elucidate the effects of SIV
infection utilizing global gene expression profiling on infected
macaque primary cells.
Global gene expression profiling is increasingly used as a
tool to study the complexities of virus–host interactions.
Recently, microarray-based studies have been published on
HSV (Kent and Fraser, 2005), rabies (Wang et al., 2005), and
Fig. 1. Levels of SIV gag protein (p27) reflect the progression of viral infection.
The chart tracks p27 levels for all three infected animals through 10 days post-
infection. Animals 83 and 84 show “normal” progression with p27 levels
peaking around 6 days post-infection. Animal 95 shows no progression of
infection despite repeated attempts to expose these cells to virus.
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focused on in vitro infections that are performed using
immortalized cell lines under conditions in which the majority
of cells become infected. Although a high rate of infection is
advantageous for measuring gene expression changes, it does
not represent the typical state of in vivo infections, and cell lines
by definition have properties that are quite distinct from primary
cells. In addition, a cell line that supports the highest level of
infection may not be representative of the natural target cell (in
terms of tissue or species origin) (Kim et al., 2001), or for
certain viruses, a cell line susceptible to infection may not be
available. Another significant consideration is that, in vivo,
changes in cellular gene expression may occur in direct
response to virus infection or in reaction to intercellular signals
from neighboring cells, which may be of a different type and
which may or may not be infected. The use of cell lines excludes
the ability to study this important aspect of the host response to
infection.
Many of these factors come into play when studying cellular
gene expression changes in response to infection with simian
immunodeficiency virus. For example, although SIV readily
infects a number of T-cell lines (Agy et al., 1991), these cells are
of human origin and similar nonhuman primate lines are not
available. We therefore sought to determine whether DNA
microarray analysis could be applied to an experimental system
that is more representative of SIV infection in vivo.
Gene expression profiling of SIV-infected PBMC presents a
number of challenges. In particular, only specific subsets of
cells within a population of PBMC are susceptible to SIV
infection (Takahashi et al., 2005), and even among the
potentially susceptible CD4+ cells, the infection rate is low.
This makes it difficult to detect gene expression changes that are
specific to virus-infected cells. However, the in vitro infection
of PBMC provides an easily manipulated experimental system
in which to detect gene expression changes that result from
intracellular as well as intercellular signaling mechanisms (Yu et
al., 2005). This system therefore provides an opportunity to gain
new insights into the genes and molecular pathways that are
active in PBMC during an in vivo infection, such as the
experimental infection of rhesus macaques.
This animal model is widely used for evaluating therapeutic
and vaccine strategies and provides valuable insights into
immunodeficiency virus pathogenesis (Reimann et al., 2005),
the host response to infection (Staprans et al., 2004), and AIDS
(Gardner, 1989). The studies described in this report contribute
to an expanding knowledge base of the molecular events that
occur in response to SIV infection and serve as a foundation for
gene expression analyses performed on cells and tissues from
SIV-infected macaques.
Results and discussion
PBMC from different rhesus macaques exhibit varying
infection kinetics
SIVmac239 infections in cell lines and primary cells rarely
achieve a very high infection rate due to the inability to createhigh titer viral stocks. It is common for infection rates to be lower
than 5% in primary cells, such as activated PBMC. However,
this is more indicative of SIV/HIV infection in vivo (Zhu et al.,
2004). To characterize our PBMC infections, we monitored cell
viability, SIV gag protein (p27) level, and the percentage of
infected cells. Cell viability was similar for each culture at each
time point and remained in excess of 90% throughout the
experiments (data not shown). SIV gag levels reflect normal
progression of viral infection for animals 83 and 84 but indicate a
lack of infection in animal 95 (Fig. 1). The PBMC for all three
animals (animals 83, 84, and 95) were infected at the same
TCID50, and the infection rate was estimated using immunoflu-
orescence (IFA). For animals 83 and 84, the infection rate was
estimated to be 3–5% (Fig. 2). Exposure of PBMC from animal
95 to SIV yielded a very different result. After three attempts at
infection, the best infection rate achievedwas b1% (estimated by
IFA at culture day 6). The viability of the cells was not affected
by the virus, and the PBMC for all three animals had the same
trend in viability, decreasing over time. This is due to the effects
of primary cells in culture rather than the virus, since the
infection rate is so low. Syncitia were not observed at any time
point. The most notable difference between PBMC samples
from animals 83 and 84 and animal 95 is seen in the FACS data
(Table 1). PBMC from animal 95 were seen to contain overall
lower percentages of CD2+ and CD4+/CD8+ cells and higher
levels of CD20+ and CD16+ cells relative to the concentrations
seen in the samples from animals 83 and 84. Also, while the
CD16+(NK) cells were at a greater concentration in animal
95 samples, this population consisted of a high population of
CD16+/CD8+/CD3+ cells (NKT cells). Animals 83 and 84 had
much lower levels of NK cells overall, but in these animals that
population consisted of almost equal parts CD16+/CD8+/CD3−
and CD16+/CD8+/CD3+ cells. This more mixed population of
cells is more typical of what is generally seen in PBMC. We
speculate that at least some of the disparity in response between
these animals is due to the disproportionately higher levels of B
and NK cells and lower levels of T cells seen in animal 95.
Fig. 2. Indirect Immunofluorescent Assay (IFA) in PBMC infected for 6 days with SIVmac239. On the left are phase contrast micrographs of virus-infected cells from
all three animals used in the experiments. On the right are the immunofluorescence analyses of the identical microscopic field. Animals 83 and 84 exhibit an estimated
infection rate of 3–5%, while the infection rate for animal 95 is b1%. There is approximately the same number of cells per field.
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unique response to viral challenge relative to animals 83 and
84
To determine if these individual differences in response to
infection can be categorized using functional genomics, we
used differential gene expression analysis using human cDNA
arrays. At the time these experiments were performed, the only
array platform for macaque studies was the human array.
Although the use of human cDNAs to measure gene expression
changes in macaque cells is suboptimal, the high nucleotide
sequence homology between humans and macaques makes this
cross-species hybridization feasible (Baskin et al., 2004; George
et al., 2003; Vahey et al., 2003). While macaques have been
shown to have greater than 97% homology to humans at the
DNA level, it is expected that some genes may be missed
entirely or that cross-hybridization may confound the data.
Without the availability of better macaque-specific resources,
these issues until very recently had been unavoidable.
In an attempt to ameliorate some of these confounding
factors, we have used stringent statistical analysis (2-fold
change, P ≤ 0.01).
It may be anticipated that use of PBMC would detect a larger
number of differentially expressed genes than use of a cell line.
A preliminary comparison of our results with gene expressionchanges associated with SIV infection of a human T-cell line (in
which nearly 100% of the cells become infected) suggests that
this is indeed the case (Li and Katze, unpublished observations).
Similarly, gene expression measurements of human T-cell lines
infected with human immunodeficiency virus (Corbeil et al.,
2001; Geiss et al., 2000) also resulted in the detection of
somewhat fewer differentially expressed genes but often with
larger gene expression changes than we detected using PBMC.
Thus, PBMC are better than less complex systems at revealing
more subtle differential gene regulation during SIV infection,
provided such changes are of a sufficient magnitude to detect
when expressed by only a small percentage of cells.
Cellular gene expression patterns were profiled for each
culture at days 3, 6, and 8 post-infection. The first step in
analyzing the resulting gene expression data was to identify all
genes that were differentially expressed by 2-fold or greater
(P ≤ 0.01) in response to SIV infection at any time point. In
animals 83 and 84, this resulted in the identification of 1585 and
654 genes, respectively. Far fewer differentially expressed
genes (310) were identified in the cultures from animal 95.
Similarly, the greatest number of differentially expressed genes
was detected in animals 83 and 84 at days 3 and 6, the time
points that corresponded to the highest p27 levels for each
culture. By day 8 post-infection, the cells were dying from
culture conditions regardless of infection status. These results
Table 1
FACS analysis of whole blood and peripheral blood mononuclear cells
(PBMCs) reveals distinct changes in lymphocyte subsets between infectible
and uninfectible animals
Animal 83 84 95 83 84 95
Source Whole
blood
Whole
blood
Whole
blood
PBMC
culture
PBMC
culture
PBMC
culture
CD2+ 73.9 70.3 81.7 99.3 99.7 85.1
CD4+/CD8− 38.6 45.6 40.0 23.4 30.7 14.7
CD8+/CD4− 39.7 26.9 43.6 54.2 49.6 67.2
CD4+/CD8+ 0.9 1.6 1.2 12.4 19.0 2.6
CD20+ 24.5 28.0 16.7 0.3 0.0 5.8
CD3+ 67.7 68.9 79.1 99.3 98.5 94.0
CD4+/CD3+ 39.5 47.2 41.1 35.8 49.6 17.2
CD8+/CD3+ 23.9 20.4 36.7 65.6 66.8 68.1
CD8+/CD3− 16.7 8.0 8.1 1.0 1.8 1.7
CD16+ 13.3 13.2 16.3 2.0 2.6 11.2
CD16+/CD8+/
CD3+
11.4 13.6 51.6 51.0 38.3 91.7
CD16+/CD8+/
CD3−
67.1 53.6 29.4 34.2 48.4 0.0
Whole blood and PBMCs were collected from the indicated macaques at time X
post-infection with SIV. Macaque 95 was not readily infected and FACS analysis
revealed significant changes in lymphocyte distribution in PBMC cultures from
this animal. While there was not an overall change in T cell (CD3+) numbers in
PBMC cultures from this animal, there was a skewed distribution of T cell
subsets, with an increase in CD4−CD8+ cells and a decrease in CD4+CD8+
cells compared to macaques 83 and 84. Most strikingly, macaque 95 displayed a
significant increase in CD16+ cells in PBMC cultures compared to animals 83
and 84. This was due to an increase in NKT cells (CD16+CD8+CD3+). The
overall increase in CD16+ cells in PBMCs in macaque 95 masked a decrease in
NK cells (CD16+CD8+CD3−) in this animal. While there was not an overall
difference in total CD16+ cells in whole blood from macaque 95, the same trend
that was observed in PBMC cultures from this animal was also observed in
whole blood, with a relative increase in NKT cells and a decrease in NK cells
compared to animals 83 and 84.
Fig. 3. Changes in gene expression in response to SIV infection vary between
individuals. The Venn diagrams depict the number of differentially expressed
genes (≥2-fold change, P value≤0.01) that are unique to or common among the
analyzed samples. Animal 95 exhibits little or no overlap with the other animals
at any time point considered in this study. Animals 83 and 84 show common
regulation of genes tightly associated with SIV infection (184 genes on day 3
and 50 on day 6) as well as a large number of genes uniquely regulated in each
individual.
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and will not be considered in our comparisons (data not shown).
Hierarchical clustering was then used to compare and
visualize gene expression changes over time for each culture.
The resulting cluster diagram again revealed that animals 83 and
84 exhibited similarities in their patterns of gene expression on
day 3 post-infection, and animal 95 exhibited a completely
different pattern in response to the virus (Fig. 3). While there
were similarities in the response patterns between animals 83
and 84, only 12% (184) of the overall genes with altered
expression patterns on day 3 post-infection were in common
between the two. Relatively few gene expression changes were
common across multiple time points, highlighting the appar-
ently ever-changing state of the cellular response to infection
with many new gene expression changes occurring at each time
point. Most likely, this is in response to the changing dynamics
associated with viral replication.
SIV-induced changes in gene expression are associated with
transcriptional regulation and immune response pathways
To characterize further the cellular response to SIV infection,
we classified differentially expressed genes into functional
categories. This analysis was performed using FatiGO (Al-
Shahrour et al., 2004), a World Wide Web-based tool for theextraction of Gene Ontology (GO) information (Harris et al.,
2004). Not surprisingly, animals 83 and 84 showed perturba-
tions in relatively large numbers of genes involved in
transcriptional regulation (112 and 35 genes), immune response
(61 and 27 genes), and protein metabolism (165 and 80 genes,
respectively). Heat map patterns between animals 83 and 84
were visibly similar in these functional categories while the heat
map of animal 95 clearly differed (Fig. 4). Expression changes
in these genes most likely reflected the active transcriptional
and translational processes associated with viral infection as the
virus usurps cellular processes to support the generation of
progeny virus and the host cells attempt to mount an
immunological response to invasion. All of these perturbations
should be predictable from the experimental conditions being
tested. Animal 95, having considerably fewer altered genes
overall (only 163 genes across all time points combined),
exhibited perturbations in protein metabolism and, to a much
lesser degree, regulation of transcription.
Analysis of the pathways associated with differentially
expressed genes highlights a number of hallmarks of viral
infection
In an attempt to attach more meaningful information to the
lists of regulated genes in each animal, the data were next
Fig. 4. Heatmap generated in Resolver™ provides a visual representation of similarities and differences seen in gene expression over three GO-derived functional
categories. The images from animals 83 and 84 show clearly similar patterns in regulation of gene expression at days 3 and 6 post-infection in protein metabolism,
transcription, and immune response—the top three categories exhibiting perturbation based on FatiGO analysis. Responses seen in samples from animal 95 vary
greatly relative to those of the other animals as would be expected based on the IFA and p27 information for these samples.
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web-based, analytical software overlays genes of interest onto
functional pathway data from three open-source resources:
KEGG (www.genome.ad.jp), BioCarta (www.biocarta.com),
and GenMAPP at (www.genmapp.org). Using our list of
genes with expression levels altered by greater than 2-fold
(P ≤ 0.01), we detected perturbations in a number of
pathways already described in the literature as being affected
by SIV (or HIV-1) infection. While few if any pathways were
significantly perturbed in animal 95, the response seen in
animals 83 and 84 showed a number of hallmarks of SIV
infection, including perturbations in the mCalpain pathway
(Fig. 5), which is responsible for cell motility in response to
integrin signaling (Ghibelli et al., 2003) and which plays arole in modulating HIV-1 entry to CD4+ cells (Tardif and
Tremblay, 2005), the MAPK signaling pathway (Popik and
Pitha, 1998), the complement pathway (Horakova et al.,
2004), and the T and B cell receptor signaling pathways (Luo
and Peterlin, 1997). While these responses involved many of
the same genes across animals and time points, some
individual variation was seen as well. For example, in the
case of the complement pathway, which is responsible for
attracting immune cells and increasing phagocytotic clearance
of infected cells during immune response, both animal 83 and
84 showed similar strong down-regulation of C8A expression,
while animal 83 showed a much stronger regulation of the
pathway overall, including changes in C5 and BF (data not
shown).
Fig. 5. The mCalpain pathway is instrumental in cell motility and cytoskeletal restructuring in response to integrin signaling. Recently, it has been shown that free
lateral movement of LFA-1 and a dynamic cytoskeleton are important in viral entry into CD4+ T cells. The heatmap shows a total of 11 genes affiliated with the
mCalpain pathway being regulated over the course of our infections for both animals 83 and 84.
247M.J. Thomas et al. / Virology 348 (2006) 242–252Trends in canonical pathway regulation differentiate the
response of individual animals
Finally, lists of regulated genes from each animal were
run through the commercially available Ingenuity Pathway
Analysis (IPA) Software. Similar to the Pathway Miner
application, IPA imports genes of interest along fold change
information and other statistical measurements and generates
information regarding how these genes interact with one
another and their potential effects in the samples of interest.
IPA provides not only networks of interactions between
genes and pathway information but also allows point and
click access to information vetted from the literature by their
scientific staff. Analysis of the canonical pathways in
Ingenuity provides some results that are similar to those
seen in Pathway Miner. For example, the ERK/MAPK and
B- and T-cell receptor signaling pathways are, as expected,
clearly represented in the highest level graphical view of the
analysis.
The Antigen Presentation pathway – which one would
expect to see regulated in most viral infections and is clearlyTable 2
Genes from the antigen presentation pathway show significant changes early in infe
Again, animal 95 exhibits no significant changes. The gray boxes indicate fold-chanreported as a regulated pathway in cases of immunodeficiency
diseases (Steinman et al., 2003) – did not appear to be
regulated in a significant fashion based on the Pathway Miner
results (only 2 genes reported a significant fold change in
animal 83 and only 1 in animal 84). Taking the literature
information into account from the IPA software, this pathway
shows regulation at 5 (animal 83) or 6 (animal 84) individual
genes at day 3 and then exhibits a reduced response (regulation
at 3 genes in each animal) for day 6. While the two animals
show regulation of some genes in common (HLA-DQB1,
HLA-DRB1, and HLA-DRB5), or at least genes from the same
MHC class II subtypes (HLA-DPA1, HLA-DMA, and HLA-
DQA2), they also show some genes that are only significantly
regulated in each animal individually. Closer examination
shows that while regulation of these “unique” responding
genes does not meet our criteria for significance in both
animals, the genes do exhibit some degree of regulation in both
animals and are all considerably more perturbed in animals 83
and 84 than in animal 95 (Table 2).
Patterns of response similar to that seen in the Antigen
presentation pathway (high initial response on day 3 withction for both animals 84 and 83 with regulation decreasing over time
ges that meet our statistical cut-offs.
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be seen in animals 83 and 84 in the endoplasmic reticulum (ER)
stress, integrin signaling, IGF-1 signaling, apoptosis signaling,
and ERK/MAPK pathways (Fig. 6). Response patterns between
the two animals are similar for a number of other pathways and
correspond to hallmarks of persistent viral infection reported in
the literature. These include chemokine and Jak/STAT signaling
(Mellado et al., 2001), TGFB signaling (Bettaccini et al., 2005),
and PI3K/AKT signaling (Mizutani et al., 2004) (data not
shown).
We were able to find a consistently regulated network of
genes that were common to both animals 83 and 84 (Fig.
7A). Networks are sets of genes that are biologically related
based on references in the literature. A heat map of the genes
from this network clearly shows the consistency of regulation
between the two infected animals as well as the distinct
pattern seen in the apparently uninfected animal 95 (Fig. 7B).
At day 3 post-infection, this entire group of genes was seen to
be regulated in both animals, and two of these genes, Egfr
and Angpt2, show consistent regulation in both animals at
day 6 post-infection. This particular network of genes centers
around Egfr, a known target for down-regulation by gag
(Valiathan and Resh, 2004). The up-regulation of Cdkna1
seen in these samples may be important, as a deficiency in
this particular protein reportedly ameliorates systemic auto-
immunity (Lawson et al., 2004). Other genes contained in this
network worth noting include Mcm7 and Mcm5 which are
essential for initiation of eukaryotic genome replication (Tsao
et al., 2004), and Fkbp4 which interacts with Irf4 to play a
role in immunoregulatory gene expression in T and B
lymphocytes (Mamane et al., 2002).Fig. 6. Similarities in pattern of response to viral infection between animals 83, 84, and
IPA software was used to generate lists of pathways seen to be significantly impacte
time points for pathways, including antigen presentation, endoplasmic reticulum
recognizable using this software.SIV Tat and/or Vpr may play a direct role in regulating the
expression of select host genes
As a means to further identify differentially expressed genes
that may be relevant to immunodeficiency virus infection, we
compared our list of differentially expressed genes with the
cellular genes listed in the HIV-1, Human Protein Interaction
Database (NIAID HIV Protein Interaction Project). Using this
approach, we identified genes with ≥2-fold change in
expression (in at least one experiment) that encode proteins
that have a previously reported direct association with one or
more HIV-1 proteins. Although the bulk of the reports in the
HIV-1-Human Protein Interaction Database describe protein–
protein interactions, a few deal specifically with the regulation
of gene expression. In this regard, our microarray analyses
detected the up-regulation of ARHGDIA and VIL2 (Matarrese
et al., 2000), RELA (Leifert et al., 2003), CCR2 (McManus et
al., 2000), and ITGA5 (Maroder et al., 1996) which have been
reported previously in association with Vpr and/or Tat. In
contrast, several genes reported to be up-regulated by Tat
(HLA-E and HLA-G; Leifert et al., 2003) or Vpr (CDH1
(Matarrese et al., 2000) and IFNG (Rautonen et al., 1994)) were
either down-regulated or unchanged in our analyses.
Although it can be difficult to make comparisons across
divergent experimental platforms, we envision the use of such
databases and the ability to integrate gene expression,
proteomic, and protein interaction data will be at the foundation
of future efforts aimed at a comprehensive understanding the
response of cells and tissues to viral infection. For example, it is
apparent that not all changes in gene expression result in a
corresponding change in the level of protein production and95 at days 3 and 6 post-infection highlight common hallmarks of viral infection.
d by our SIV infections in these samples. Consistent patterns of response across
stress, and ERK/MAPK, IGF-1, integrin, and apoptosis signaling, are readily
Fig. 7. Network of inter-related genes based on literature information that are seen to be similarly regulated in infections from animals 83 and 84. (A) An example of an
Ingenuity Network describing a group of genes regulated in animal 83. This network of genes centers around Egfr, a known target for down-regulation by gag. (B)
Heat map of all genes represented in the network. The heat map illustrates the consistency of regulation between the two infected animals as well as the distinct pattern
seen in the apparently uninfected animal 95.
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function or activity (Ideker et al., 2001). Therefore, by
integrating diverse types of data, we can obtain a clearer
picture of the biological significance of the individual cellular
responses detected. Protein interaction data may be particularly
important in this regard, and software tools are now available
for modeling complex protein-interaction networks (Shannon et
al., 2003), and gene expression and proteomic data can be
overlaid onto the network to enhance our understanding of the
biological processes at work (Prinz et al., 2004; Rand
Corporation and Elisa Eiseman, 2004).
Our observations of SIV-induced changes in the expression
of genes associated with lymphocyte response and metabolicprocesses, such as cell growth and maintenance, nucleic acid
or protein metabolism, or metabolic regulation, are in general
similar to those reported (Vahey et al., 2002) in studies
examining gene expression changes in human PBMC
responding to HIV infection. HIV was also observed to elicit
a transcriptional response in genes associated with cellular
activation, transcription, translation, and the immune re-
sponse. Similar to our findings, the majority of genes
differentially expressed in response to HIV exhibited an
increase in expression and decreases in gene expression
occurred primarily at later time points. Coordinated patterns
of cellular gene expression were also reported, but similar to
our results, the number of genes that exhibited a coordinated
250 M.J. Thomas et al. / Virology 348 (2006) 242–252or sustained response over the duration of the experiment was
limited.
In conclusion, our results from these experiments show that
individuals supposedly on the same path to disease (such as
animals 83 and 84) still exhibit individual variation at the level
of gene transcription. We also saw that our animal 95 could
provide insight into how certain infected individuals become
long-term nonprogressors.
These results highlight the importance of individual variation
in response to viral infection. It will be important to discover
with greater precision the factors involved in determining these
different responses to viral challenge, as they could provide
insights into potential cures or vaccines for HIVas well as allow
for more efficient use of declining nonhuman primate resources
in these types of experiments. These data also provide a novel
resource for members of the HIV research community as the
first whole animal, nonhuman primate, microarray-based
experiment of its kind. Our continuing development of a
rhesus-specific microarray will allow for greater elucidation of
the mechanisms and pathways being altered in these kinds of
infections.
Materials and methods
PMBC preparation
Peripheral blood was collected from three healthy rhesus
macaques (M. mulatta), termed animals 83, 84, and 97, and
PBMC were recovered by standard Ficol density-gradient
centrifugation. The recovered cells were then washed, counted,
and placed at a density of 2 × 106 cells/ml in complete RPMI
1640 growth medium containing 10% fetal bovine serum and
5% lectin-purified IL-2 (Roche Diagnostics). Phytohemagglu-
tinin (Sigma Chemical) was then added at a concentration of
5μg/ml, and after a 24-h incubation period, the medium was
replaced with fresh complete medium and the culture was
incubated at 37 °C for 3 days. The resulting phytohemagglu-
tinin-activated cells were then filtered to remove dead and
aggregated cells, counted, and divided.
Virus infection
Unfractionated PBMC (5 × 106 cells/ml) from each of the
three animals were infected with SIVmac239 (grown in
CEMx174 cells) at a multiplicity of 0.01 TCID50/cell or
mock-infected with a volume of culture supernatant from
uninfected CEMx174 cells equal to the volume of virus stock.
After a 30-min incubation period at 37 °C, unattached virus
was removed by 3 washes with phosphate-buffered saline.
Mock-infected cells were washed in the same manner. The cells
were then divided into 12-well tissue culture plates at 2 × 106
cells/well in 3 ml of complete medium per well per animal. For
each animal, a single well of cells was harvested at each time
point, and cells in the remaining wells were maintained by
replacing 1.5 ml of medium with fresh medium at 48-
h intervals. Cells were counted at harvesting and the percentage
of viable cells was determined by trypan blue dye exclusion.The cells were then collected by centrifugation and lysed in
solution D as described previously (Chomczynski and Sacchi,
1987). Culture supernatants were monitored for p27 levels by
antigen-capture ELISA (ZeptoMetrix Corp.). The percentage of
infected cells was estimated by indirect immunofluorescence
assay using pooled sera from SIV-infected macaques (Agy et
al., 1991).
Microarray analysis
For cDNA array analysis, total RNAwas isolated by the acid
guanidinium thiocyanate-phenol/chloroform extraction method
(Chomczynski and Sacchi, 1987) and amplified twice using the
RiboAmp RNA amplification system (Arcturus). The quantity
and quality of total amplified RNAwere evaluated by capillary
electrophoresis using an Agilent Technologies 2100 Bioanaly-
zer. First-strand cDNA synthesis, probe labeling, and micro-
array hybridizations were performed as described previously
(Geiss et al., 2001). Labeled probes derived from SIV-infected
cells were co-hybridized with probes derived from time-
matched mock-infected control samples on microarrays con-
taining duplicate spots of cDNAs representing approximately
13,000 human genes (Agilent Technologies). Slides were
scanned with an Agilent DNA microarray scanner and image
analysis was performed using Agilent Feature Extractor
Software. Each microarray experiment was done using a dye-
swapping technique, thereby providing 4 technical replicates for
each measurement (Kerr and Churchill, 2001). Initially, genes
were selected as differentially expressed based on two criteria: a
greater than 99% probability of being differentially expressed
(P ≤ 0.01) and an expression level change of 2-fold or greater.
All data were entered into a custom-designed database,
Expression Array Manager, and then uploaded into Resolver
4.0 (Rosetta Biosoftware) and DecisionSite for Functional
Genomics (Spotfire Inc.) for analysis. Biological gene sets
(referred to as Biosets) were compiled for various cellular
processes by selecting genes of interest that were both
represented on the microarray and which had Gene Ontology
(GO) annotation (Harris et al., 2004). Once compiled, Biosets
were used to characterize and compare gene expression patterns
between experiments. These Biosets were also analyzed using
Pathway Miner (Pandey et al., 2004) and the Ingenuity Pathway
Analysis (IPA) Software (Ingenuity Systems, Mountain View,
CA) to assign functional information and biological relevance
to the groups of genes being regulated. In accordance with
proposed standards (Brazma et al., 2001), all data described in
this report, including sample information, intensity measure-
ments, gene lists, error analysis, microarray content, and slide
hybridization conditions, are available in the public domain
through Expression Array Manager at http://www.expression.
washington.edu/public.
qRT-PCR
Quantitative real-time PCR (rtPCR) was used to validate the
gene expression changes. Total RNA samples were treated with
DNase using DNA-free DNase Treatment and Removal
251M.J. Thomas et al. / Virology 348 (2006) 242–252Reagents (Ambion Inc.). Reverse Transcription was performed
using TaqMan Reverse Transcription Reagents from Applied
Biosystems (ABI). Primer and probe sets for each of the target
sequences were designed using macaque EST sequences
available from Macaque.org and mapping them to the M.
mulatta genome available fromBaylor. rtPCRwas performed on
the ABI 7500 Real-time PCR System, using TaqMan chemistry
(ABI). Each target was run in quadruplicate, with 20 μL reaction
volumes of TaqMan 2× PCR Universal Master Mix (ABI).
GAPDH and 18S were chosen as endogenous controls to
normalize quantification of the target. Quantification of each
gene relative to the calibrator was calculated by the instrument
using the standard equation in the ABI Sequence Detection
Software version 1.3:2−ΔΔCT. The probe used for SIV gag was
previously described (Leutenegger et al., 2001).
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